Want to join the conversation?
$APD expects 3Q16 adjusted EPS from continuing operations of $1.87-1.92, up 13-16% from last year. For FY16, $APD lifted adjusted EPS from continuing operations guidance to $7.40-7.55 from prior estimate of $7.25-7.50. The revised forecast represents a 12-14% growth over last year. The capital expenditures forecast of FY16 is about $1.2Bil.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?